141 related articles for article (PubMed ID: 27404920)
1. Structural Characterization of H1N1 Nucleoprotein-Nucleozin Binding Sites.
Pang B; Cheung NN; Zhang W; Dai J; Kao RY; Zhang H; Hao Q
Sci Rep; 2016 Jul; 6():29684. PubMed ID: 27404920
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Novel Complex between the Nucleoprotein and PA(1-27) of Influenza A Virus Polymerase.
Vidic J; Noiray M; Bagchi A; Slama-Schwok A
Biochemistry; 2016 Aug; 55(31):4259-62. PubMed ID: 27431776
[TBL] [Abstract][Full Text] [Related]
3. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A
Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and inhibitory effects of novel pyrimido-pyrrolo-quinoxalinedione analogues targeting nucleoproteins of influenza A virus H1N1.
Lin MI; Su BH; Lee CH; Wang ST; Wu WC; Dangate P; Wang SY; Huang WI; Cheng TJ; Lin OA; Cheng YS; Tseng YJ; Sun CM
Eur J Med Chem; 2015 Sep; 102():477-86. PubMed ID: 26310893
[TBL] [Abstract][Full Text] [Related]
5. Development of an anti-influenza drug screening assay targeting nucleoproteins with tryptophan fluorescence quenching.
Hung HC; Liu CL; Hsu JT; Horng JT; Fang MY; Wu SY; Ueng SH; Wang MY; Yaw CW; Hou MH
Anal Chem; 2012 Aug; 84(15):6391-9. PubMed ID: 22712523
[TBL] [Abstract][Full Text] [Related]
6. Interaction of Host Nucleolin with Influenza A Virus Nucleoprotein in the Early Phase of Infection Limits the Late Viral Gene Expression.
Kumar D; Broor S; Rajala MS
PLoS One; 2016; 11(10):e0164146. PubMed ID: 27711134
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
Cheng H; Wan J; Lin MI; Liu Y; Lu X; Liu J; Xu Y; Chen J; Tu Z; Cheng YS; Ding K
J Med Chem; 2012 Mar; 55(5):2144-53. PubMed ID: 22332894
[TBL] [Abstract][Full Text] [Related]
8. Mutations Conferring Increased Sensitivity to Tripartite Motif 22 Restriction Accumulated Progressively in the Nucleoprotein of Seasonal Influenza A (H1N1) Viruses between 1918 and 2009.
Pagani I; Di Pietro A; Oteiza A; Ghitti M; Mechti N; Naffakh N; Vicenzi E
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624498
[TBL] [Abstract][Full Text] [Related]
9. Nucleozin targets cytoplasmic trafficking of viral ribonucleoprotein-Rab11 complexes in influenza A virus infection.
Amorim MJ; Kao RY; Digard P
J Virol; 2013 Apr; 87(8):4694-703. PubMed ID: 23408618
[TBL] [Abstract][Full Text] [Related]
10. Identification of influenza A nucleoprotein as an antiviral target.
Kao RY; Yang D; Lau LS; Tsui WH; Hu L; Dai J; Chan MP; Chan CM; Wang P; Zheng BJ; Sun J; Huang JD; Madar J; Chen G; Chen H; Guan Y; Yuen KY
Nat Biotechnol; 2010 Jun; 28(6):600-5. PubMed ID: 20512121
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of conserved amino acids in the influenza A virus nucleoprotein.
Li Z; Watanabe T; Hatta M; Watanabe S; Nanbo A; Ozawa M; Kakugawa S; Shimojima M; Yamada S; Neumann G; Kawaoka Y
J Virol; 2009 May; 83(9):4153-62. PubMed ID: 19225007
[TBL] [Abstract][Full Text] [Related]
12. A GFP-tagged nucleoprotein-based aggregation assay for anti-influenza drug discovery and antibody development.
Antony H; Schaeffer PM
Analyst; 2013 Oct; 138(20):6073-80. PubMed ID: 23961535
[TBL] [Abstract][Full Text] [Related]
13. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA.
Ye Q; Krug RM; Tao YJ
Nature; 2006 Dec; 444(7122):1078-82. PubMed ID: 17151603
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic study of intertypic nucleoprotein complex formation and its inhibitory effect toward influenza A virus.
Narkpuk J; Jaru-Ampornpan P; Subali T; Bertulfo FC; Wongthida P; Jongkaewwattana A
Virology; 2015 Nov; 485():104-15. PubMed ID: 26218215
[TBL] [Abstract][Full Text] [Related]
15. Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein.
White KM; Abreu P; Wang H; De Jesus PD; Manicassamy B; García-Sastre A; Chanda SK; DeVita RJ; Shaw ML
ACS Infect Dis; 2018 Feb; 4(2):146-157. PubMed ID: 29268608
[TBL] [Abstract][Full Text] [Related]
16. TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Influenza A Virus Infection.
Patil G; Zhao M; Song K; Hao W; Bouchereau D; Wang L; Li S
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899090
[TBL] [Abstract][Full Text] [Related]
17. Detection of nonhemagglutinating influenza a(h3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus culture.
van Baalen CA; Els C; Sprong L; van Beek R; van der Vries E; Osterhaus AD; Rimmelzwaan GF
J Clin Microbiol; 2014 May; 52(5):1672-7. PubMed ID: 24622097
[TBL] [Abstract][Full Text] [Related]
18. Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition.
Nilsson-Payant BE; Blanco-Melo D; Uhl S; Escudero-Pérez B; Olschewski S; Thibault P; Panis M; Rosenthal M; Muñoz-Fontela C; Lee B; tenOever BR
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568513
[TBL] [Abstract][Full Text] [Related]
19. Organization of the influenza virus replication machinery.
Moeller A; Kirchdoerfer RN; Potter CS; Carragher B; Wilson IA
Science; 2012 Dec; 338(6114):1631-4. PubMed ID: 23180774
[TBL] [Abstract][Full Text] [Related]
20. p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein.
Panagiotopoulos A; Tseliou M; Karakasiliotis I; Kotzampasi DM; Daskalakis V; Kesesidis N; Notas G; Lionis C; Kampa M; Pirintsos S; Sourvinos G; Castanas E
Pharmacol Res Perspect; 2021 Aug; 9(4):e00798. PubMed ID: 34128351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
